OpenURL Connection Search

Select item for more details and to access through your institution.

CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.
Published in:
International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1237, doi. 10.3390/ijms20051237
By:
- Sharma, Bhawna;
- Nannuru, Kalyan C.;
- Saxena, Sugandha;
- Varney, Michelle L.;
- Singh, Rakesh K.
Publication type:
Article
ACVR1<sup>R206H</sup> receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.
Published in:
Science Translational Medicine, 2015, v. 7, n. 303, p. 1, doi. 10.1126/scitranslmed.aac4358
By:
- Hatsell, Sarah J.;
- Idone, Vincent;
- Alessi Wolken, Dana M.;
- Huang, Lily;
- Kim, Hyon J.;
- Lili Wang;
- Xialing Wen;
- Nannuru, Kalyan C.;
- Jimenez, Johanna;
- Liqin Xie;
- Das, Nanditha;
- Makhoul, Genevieve;
- Chernomorsky, Rostislav;
- D’Ambrosio, David;
- Corpina, Richard A.;
- Schoenherr, Christopher J.;
- Feeley, Kieran;
- Yu, Paul B.;
- Yancopoulos, George D.;
- Murphy, Andrew J.
Publication type:
Article
Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion.
Published in:
International Journal of Cancer, 2010, v. 126, n. 2, p. 328, doi. 10.1002/ijc.24714
By:
- Singh, Seema;
- Sadanandam, Anguraj;
- Varney, Michelle L.;
- Nannuru, Kalyan C.;
- Singh, Rakesh K.
Publication type:
Article
Transforming growth factor-β signaling at the tumor–bone interface promotes mammary tumor growth and osteoclast activation.
Published in:
Cancer Science, 2009, v. 100, n. 1, p. 71, doi. 10.1111/j.1349-7006.2008.01012.x
By:
- Futakuchi, Mitsuru;
- Nannuru, Kalyan C.;
- Varney, Michelle L.;
- Sadanandam, Anguraj;
- Nakao, Kimihisa;
- Asai, Kiyofumi;
- Shirai, Tomoyuki;
- Sato, Shin-ya;
- Singh, Rakesh K.
Publication type:
Article

Found: 4

CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.

ACVR1<sup>R206H</sup> receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.

Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion.

Transforming growth factor-β signaling at the tumor–bone interface promotes mammary tumor growth and osteoclast activation.